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ABSTRACT
The Effects of Age at Infection and Gender on the Pathogenesis of Theiler’s 
Virus Induced Disease – a Model of Human Multiple Sclerosis (April 2008)
Matthew Stephen Propst
Department of Biomedical Science
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Texas A&M University
Fellows Advisor: C. Jane Welsh, Ph.D.
Department of Veterinary Integrative Biosciences
Multiple sclerosis (MS) is the most common inflammatory demyelinating disease 
of the central nervous system (CNS) affecting 1 in 2000 of the US population.
Susceptibility to MS is influenced by environmental, gender, genetic and pathogenic 
factors.  For instance, there is a higher incidence of MS in women than men (2:1) and 
that there is a sudden onset of the disease between the ages of 15 and 50, suggesting 
that gender, age and puberty alter the susceptibility to the disease. The etiology of MS is 
not known, and although viral infection is suspected to be an initiating event.
Theiler’s murine encephalomyelitis virus (TMEV) infection in SJL mice causes a 
biphasic disease in which the chronic phase causes an inflammatory demyelinating 
disease of the CNS which closely resembles MS. In the current study we utilize TMEV 
to investigate the influence of both age and gender on disease progression in this viral 
model of human multiple sclerosis.  Here, we tested the hypothesis that age and gender 
significantly affect the pathogenesis of Theiler’s virus-induced disease in which we 
showed that males displayed worse symptoms than females at later ages of inoculation.
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1 I  INTRODUCTION 1
In order to understand the pathogenesis and treatment of human diseases, it is 
important to develop animal models.  One of the best models for multiple sclerosis (MS) 
is Theiler’s virus infection in mice.  Experiments on Theiler’s murine encephalomyelitis 
virus (TMEV) have been performed since its discovery by Max Theiler in 1934 and his 
continued research in 1937 (Theiler, 1934; Theiler, 1937). The etiology of MS is not 
known, although viral infection is suspected to be an initiating event.  Due to 
epidemiological studies of MS (Johnson, 1975; McFarlin and McFarland, 1982), “the 
identification of viral antigens and virus-specific antibodies” (Soldan et al., 1997; Fuller 
et al., 2007) and the “detection of HHV-6 DNA…as a marker of active viral infection” 
(Soldan et al., 1997), it is thought that viral agents help create the initial tissue damage 
that leads to autoimmunity and multiple sclerosis. Comparably, chronic TMEV causes a 
similar inflammation of central nervous system (CNS) tissues, therefore providing an 
excellent model for MS (Daniels et al., 1952; Lipton, 1975; Dal Canto et al., 1996; 
Oleszak et al., 2004; Fuller et al., 2007).  
Multiple sclerosis (MS) is the most common inflammatory demyelinating disease 
of the central nervous system (CNS) affecting 1 in 2000 of the US population.
Susceptibility to MS is influenced by environmental, gender, genetic and pathogenic 
factors.  For instance, there is a higher incidence of MS in women than men (2:1) and 
that there is a sudden onset of the disease between the ages of 15 and 50, suggesting 
that gender, age and puberty alter the susceptibility to the disease. Sex-dependent effects 
                                                
1 This thesis follows the style and format of Journal of Neuroimmunology.
2on TMEV have been researched, however, the effects of age at infection and gender on
the pathogenesis of TVID have not been studied.  CD1 mice are highly susceptible to 
TVID at three weeks of age and their susceptibility declines with age after this (Steiner 
et al., 1984).  More importantly, this study is limited to examining only one and three 
weeks of age at infection so that the trend before, during and after puberty is not 
investigated and gender effects are not isolated.  Additionally, studies with age related 
susceptibility to TVID have not been conducted in SJL/J or B10Q mice which is 
especially important since SJL/J mice develop the highest incidence of MS-like disease 
following infection with TMEV.  If MS is actually caused by a virus, it would be critical 
to study the disease in the most susceptible model so that it may be appropriate 
comparison to the most susceptible humans.
In MS, infection with the putative MS infectious agent is thought to occur before 
the age of puberty (Fischman, 1981).  Interestingly, this infectious time period coincides 
with the onset of puberty in mice as shown by prior studies (Steiner et al., 1984).  The 
physiological changes that occur during puberty may affect susceptibility to TMEV
(Fischman, 1981).  The experiment being conducted in the current study should clarify 
whether age at infection and gender are the factors that cause this deviation.
3II   METHODS
Over the years, animal models have become the standard for much of scientific 
research.  In regard to a Theiler’s virus model or any model for MS in general, some sort 
of quantitative and qualitative tests must be employed to determine severity of the 
disease.  As shown by review of literature the following tests are largely conducted by 
most scientists researching TVID, only differing on small details.
Subjects: SJL/J mice were used because their high susceptibility to TVID.  
Breeding SJL/J pairs were purchased from Harlan Laboratories (Indianapolis, IL) and 
bred in the Comparative Animal Medicine facility at Texas A&M University.  Four 
groups (infected at 1, 2 3 and 4 weeks of age) of approximately 25 mice were randomly
assigned using protocols previously described (Campbell et al., 2001; Sieve et al., 2004).  
Each group consisted of 15 infected (I) and 10 control (C) – with equal numbers of male 
(M), half female (F) mice.  Subgroups taking into account all the previously mentioned 
variables were labeled as such: 1/F/C, 1/M/C, 1/FM/I (1/F/I + 1/M/I), 2/F/C, 2/M/C, 
2/F/I, 2/M/I, 3/F/C, 3/M/C, 3/F/I, 3/M/I and 4/M/I.
Infection:  The BeAn strain of Theiler’s virus was propagated and amplified in 
BHK-21 cells.  The culture supernatant containing infectious virus was aliquoted and 
stored at -80°C before use (Welsh et al., 1987; Sieve et al., 2004).  Mice were 
anesthetized with isoflurane inhalation and either injected intracerebrally with 5.0 x 105
plaque forming units of the BeAn strain of TMEV (provided by Dr. H. L. Lipton, 
Department of Neurology, Northwestern University) in 20 µl of infection media or 20 µl 
of sterile phosphate buffered saline (PBS). 
4Physiological Indices:  Clinical signs of infection and body mass were obtained 
weekly through the duration of the experiment, beginning at infection and lasting until 
the time of sacrifice (Day 84 p.i.). The mice were scored on behavioral indications of 
encephalitic-like symptoms during the disease’s acute phase as follows: “0=no 
behavioral signs of illness, 1=ruffled fur, 2=ruffled fur and slightly hunched posture, 
3=ruffled fur, very hunched posture, and lethargic, 4=moribund” (Campbell et al., 2001; 
Sieve et al., 2004).  The mice are observed and scored based on behavior in the disease’s 
chronic phase: “0=no behavioral impairment, 1=weakness in hind limbs, 2=slightly 
wobbly gait, 3=definitely wobbly gait, 4=very wobbly gait, hunched posture, and loss of 
righting reflex, 5=all of the previously mentioned symptoms and incontinence, 
6=moribund” (Borrow et al., 1998; Sieve et al., 2004).
Rotarod Analysis: All groups were tested for decreased performance on rotarod 
starting at week 6 p.i. using an Ugo Basile Model 7650 accelerating rotarod treadmill 
(McGavern et. al., 1999; Zoecklein et. al., 2003). Prior to beginning the rota-rod 
analysis mice were familiarized with three untimed sessions on rota-rod in order to 
remove errors in times due to the mice being unaccustomed to the procedure.  Each 
mouse completed two sessions on each test date which were averaged and recorded for 
each session.  Times were taken biweekly.
Tail Bleeds: The mice were bled via the tail vein once every three weeks.   The 
mice were placed in a recovery cage until all the mice were bled and returned to their 
home cage.  They were not disturbed until the next week’s weighing and scoring to 
reduce the effects of stress on the experiment.  
5Sacrifice: At day 84 p.i., all groups were anesthetized with pentabarbitone.  
Approximately half of the samples from each group were used for histological analysis
whereas the other half were stored for viral recovery to run antibody assays to determine 
TMEV levels.
Viral Purification: Briefly, TMEV was used to infect L2 cells at an MOI of 0.1.  
Approximately 48 hours the cells were frozen and thawed 3x.  Next, the cell debris was 
cleared by centrifugation at 3,000 x g for 20 minutes.  The supernatant was collected and 
virus pelleted by ultracentrifugation at 80,000 x g for 3 hours.  The purified virus was 
resuspended in 0.1M sodium phosphate buffer. The virus was determined to be at ≥70% 
purity by SDS-PAGE.
Antibody Levels to TMEV: The serum Ig levels of mice at  time of sacrifice 
(Day 84 p.i.) was determined by ELISAs using virus that was purified as described 
previously and as done in previous studies (Young et al., 1983; Dolimbek et al., 2002; 
Steelman et. al.).  Viral sample was diluted to 1.0 μg/ml in pH 9.6, carbonate buffer 
(1.589 g Na2CO3; 2.941 g NaHCO3; 0.191 g MgCl2; fill to 1L with RO-H2O).  High 
protein binding Costar 3590 96-well plates were coated with 0.1 mL of virus/well and 
incubated at 4ºC for 48 hours.  The plates were then washed 3X by filling each well with 
wash buffer (500 mL 1X PBS; 0.250 mL Tween-20) using a squirt bottle and then rinsed 
again using a separate squirt bottle containing RO- H2O.  Plates were then blocked with 
SuperBlock buffer (containing no BSA) according to manufacturer’s instructions 
(Pierce).  Serum samples were then diluted in pH 7.2, complete assay buffer consisting 
of 99 mL Assay Buffer A (11.4 g Tris-HCl; 3.32 g Tris-Base; 8.7 g NaCl; fill to 1 L with 
6RO-H2O) and 1 mL Assay Buffer B (95 mL RO-H2O; 1.0 g Non-Fat Dry Milk; 0.5 mL 
Tween-20) to achieve a starting dilution of 1/100.  0.2 mL of diluted samples were 
across row 1 and 0.2 mL of assay buffer was added only to column 12 to serve as 
background for subtraction.  0.1 mL of assay buffer was added to remaining wells and 
samples were serially diluted down each column by transferring 0.1 mL volumes 
between the wells.  Plates were then incubated at room temperature for 90 minutes.  The 
plates were then washed 3X by filling each well with wash buffer (500 mL 1X PBS; 
0.250 mL Tween-20) using a squirt bottle and then rinsed again using a separate squirt 
bottle containing RO- H2O.  Secondary antibody was diluted 1/500 in complete assay 
buffer and 0.1 mL was added to each well.  Plates were then incubated at room 
temperature for 60 minutes.  The plates were then washed 3X by filling each well with 
wash buffer (500 mL 1X PBS; 0.250 mL Tween-20) using a squirt bottle and then rinsed 
again using a separate squirt bottle containing RO- H2O.  Reaction was then developed 
in the dark using 0.1 mL OPD substrate (Sigma) according to manufacturer’s 
instructions for 10 minutes and stopped by adding 0.05 mL of 2.0 M sulfuric acid.  OD 
was determined at 490 nm using a FLUOstar Optima (BMG Inc., Offenburg, Germany) 
and background was subtracted from each column.
Histology: At termination mice were euthanized with pentabarbitone and 
perfused via the left ventricle with PBS followed by 10% formalin.  The brains were 
removed and dehydrated and embedded in paraffin by the Histology Laboratory, 
Department of Veterinary Integrative Biosciences, College of Veterinary Medicine and 
Biomedical Sciences, Texas A&M University. The brains were sectioned coronally into 
7four blocks.  Five micron sections from each block were routinely stained with 
hematoxylin and eosin (H&E) for microscopic examination.
Statistical Analyses:  Using repeated measure analyses of variance (ANOVA), all 
data was tested at 0.05 level of significance.
This study seeks to add to the current knowledge on Theiler’s virus as an animal 
model for Multiple Sclerosis, by clarifying the effect that age of infection has on TVID 
in each gender.  It does not seek to change any previous methods, but to employ them in 
order to expand the knowledge base in order to better understand the pathogenesis of 
TVID and to hopefully apply that knowledge to better understand multiple sclerosis.  
8III   DATA AND RESULTS
Effects of Infection at 1 Week of Age: Most mice infected at one week of age 
were moribund while all were showing severe symptoms. Figure 1 (p.9) reflects 
survival until time of necessary sacrifice (6-10 days p.i.).  Mice were not yet sexed, so 
no gender results were obtained.  Table 1 shows that this observation is in general 
accordance with several studies results (Steiner; Theiler, 1934; Theiler, 1937). At one 
week of age the immune system of the mouse is not developed and therefore they are not 
able to mount a sufficient immune response to the virus.  If trying to compare these 
results to MS, paralysis of the limbs and/or death in young children would be an 
indicative sign of a possibly undiagnosed MS case.
Table 1 - Effects of Infection at 1 Week of Age:
Average Score at Sacrifice 3.23
Symptoms Number of Mice
Bilateral Front Limb Paralysis 1 of 15
Bilateral Rear Limb Paralysis 1 of 15
Unilateral (Left) Rear Limb Paralysis 1 of 15
Unilateral (Right) Rear Limb Paralysis 3 of 15
9Figure 1 - Effects of Infection at 1 Week of Age:
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Figure 2 - Effects of Infection at 2 Weeks of Age on Mass:
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Legend: 2 – Weeks Old At Infection, F – Female, M – Male, C – Control, I – Infected
Effects of Infection at 2 Weeks of Age on Mass:  During the experiment, the 
body mass of infected mice did not differ statistically from controls during the acute 
(<49 days p.i) or chronic (≥49 p.i.) phases (all ps>0.05) and males maintained their 
normally heavier body mass than females (all ps<0.05).
11
Figure 3 - Effects of Infection at 3 Weeks of Age on Mass:
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Legend: 3 – Weeks Old At Infection, F – Female, M – Male, C – Control, I – Infected
Effects of Infection at 3 Weeks of Age on Mass:  During the experiment, the 
body mass of infected mice did not differ statistically from controls during the acute 
(<49 days p.i) or chronic (≥49 p.i.) phases (all ps>0.05) and males maintained their 
normally heavier body mass than females (all ps<0.05).
12
Figure 4 - Effects of Infection at 4 Weeks of Age on Mass:
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Legend: 3/4 – Weeks Old At Infection, F – Female, M – Male, C – Control, I – Infected
Effects of Infection at 4 Weeks of Age on Mass:  During the experiment, the 
body mass of infected mice did not differ statistically from controls during the acute 
(<49 days p.i) phase or chronic (≥49 p.i.) phase (ps>0.05). 
Body Mass Summary:  Infection did not cause mice to differ statistically from 
their control counterparts during the acute (<49 days p.i) or chronic (≥49 p.i.) phases and 
males maintained their normally heavier body mass than females. Due to the large 
difference in the weights of the males compared to females, the males remain much 
heavier than the females.
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Figure 5 - Effects of Infection at 2 Weeks of Age on Rotarod Time:
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Legend: 2 – Weeks Old At Infection, F – Female, M – Male, C – Control, I – Infected
Effects of Infection at 2 Weeks of Age on Rotarod Time:  Only the males 
infected at 2 weeks of age differed from their control counterparts (p=0.0173).  Males 
infected at two weeks of age had lower times than females infected at two weeks of age 
(p=0.0001).
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Figure 6 - Effects of Infection at 3 Weeks of Age on Rotarod Time:
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Legend: 3 – Weeks Old At Infection, F – Female, M – Male, C – Control, I – Infected
Effects of Infection at 3 Weeks of Age on Rotarod Time:  Both the male and 
female groups infected at three weeks of age did not differ from their control 
counterparts or from one another (ps>0.05)
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Figure 7 - Effects of Infection at 4 Weeks of Age on Rotarod Time:
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Legend: 3/4 – Weeks Old At Infection, F – Female, M – Male, C – Control, I – Infected
Effects of Infection at 4 Weeks of Age on Rotarod Time:  Males infected at 
four weeks of age differed from their control counterparts (p=0.0101).  As previously 
explained in the method section, there are no females to discuss at this age of infection.
Rotarod Summary:  Rotarod analysis has been used with success in many 
studies as a measure for neurological deficits, however in this experiment it seems that 
only the males infected at two and four weeks of age actually differed from their control 
counterparts, meaning that infection generally created no change in rotarod time.  
16
However, when comparing males and females at each age of infection only the males 
infected at two weeks of age had lower times than the females infected at two weeks of 
age (p=0.0001).  Nevertheless, it is still not prudent to use this as a conclusion from the 
data since the females infected at two weeks of age did not even differ from statistically 
from their controls.  It does not appear that rotarod was indicative of disease in this 
study.
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Figure 8 - Effects of Infection at 2 Weeks of Age on Clinical Score:
0
0.5
1
1.5
2
2.5
3
0 7 14 21 28 35 42 49 56 63 70 77
Day Post Infection
S
co
re
2/F/C
2/M/C
2/F/I
2/M/I
Legend: 2 – Weeks Old At Infection, F – Female, M – Male, C – Control, I – Infected
Effects of Infection at 2 Weeks of Age on Clinical Score:  Both males and 
females infected at two weeks of age scored higher than their corresponding controls 
(ps<0.05).  Infected males had lower clinical scores than infected females in the chronic 
phase (p=0.0065).
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Figure 9 - Effects of Infection at 3 Weeks of Age on Clinical Score:
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Legend: 3 – Weeks Old At Infection, F – Female, M – Male, C – Control, I – Infected
Effects of Infection at 3 Weeks of Age on Clinical Score:  Infected males and 
females infected at three weeks of age scored higher than their corresponding controls 
(ps<0.05).  There was no statistical difference in the scores of infected males and 
females during the acute and chronic phases (ps>0.05).
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Figure 10 - Effects of Infection at 4 Weeks of Age on Clinical Score:
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Legend: 3/4 – Weeks Old At Infection, F – Female, M – Male, C – Control, I – Infected
Effects of Infection at 4 Weeks of Age on Clinical Score:  Males infected at 
four weeks of age scored higher than their corresponding control group in both the acute 
and chronic phases (p=0.0001).  
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Figure 11 - Effects of Infection on Clinical Score in Females:
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Effects of Infection on Clinical Score in Females: Females infected at two 
weeks of age had lower clinical scores than females infected at three weeks of age
during the acute phases of the disease (p=0.0102).  
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Figure 12 - Effects of Infection on Clinical Score in Males:
0
0.5
1
1.5
2
2.5
3
0 7 14 21 28 35 42 49 56 63 70 77
Days Post Infection
S
co
re
2/M/I
3/M/I
4/M/I
Legend: 2/3/4 – Weeks Old At Infection, F – Female, M – Male, C – Control, I – Infected
Effects of Infection on Clinical Score in Males:  Males infected at two weeks 
of age had lower clinical scores than males infected at three weeks of age in the acute 
phase (p=0.0001).   All male groups differed from one another in the chronic phase with 
those infected at three weeks of age scoring highest, four weeks of age in the middle and 
two weeks of age scoring lowest (ps<0.05).
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Clinical Score Summary:  All infected groups differed statistically from their 
control counterparts in both the acute and chronic phases of the disease.  However, 
between infected groups there was some variability.  Males infected at two weeks of age 
had lower clinical scores than females infected at two weeks of age in the chronic phase 
of the disease (p=0.0065). Females infected at two weeks of age had lower clinical 
scores overall than those infected at three weeks of age (p=0.0102).  Males infected at 
two weeks of age had lower clinical scores than those infected at three weeks of age in 
the acute phase (p=0.0001).   All male groups differed from one another in the chronic 
phase with those infected at three weeks of age scoring highest, four weeks of age in the 
middle and two weeks of age scoring lowest (ps<0.05).  What this means is that 
infection at two weeks of age for both male and females caused clinical scores to be 
lower than when infected at three weeks of age.  In addition, males clinical scores were 
lower then females when infected at two weeks of age, but ended up being statistically 
the same when infected at three weeks of age.  It appears that the males are surpassing 
the females in clinical score as puberty takes place (3-4 weeks of age).  Due to 
unfortunate circumstances no female mice that were to be infected at four weeks of age 
survived to participate in the experiment.  Luckily though, despite the lack of a group of 
females infected at four weeks of age, another study with C57L/J mice showed a higher 
severity of disease in males after puberty, reflected in the % of mice infected and the 
total IgG (Fuller, et. al 2005).  This seems to show that there is some physiological 
change taking place during that either protects females, exacerbates the condition in 
males or both.
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Figure 13 - Effects of Infection at 2 Weeks of Age on TMEV Antibody Levels:
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Legend: 2 – Weeks Old At Infection, F – Female, M – Male, C – Control, I – Infected
Effects of Infection at 2 Weeks of Age on TMEV Antibody Levels:  Infected 
mice had higher levels of virus-specific antibody than controls (ps<0.05).  Males 
infected at two weeks of age were the same as females infected at two weeks of age.
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Figure 14 - Effects of Infection at 3 Weeks of Age on TMEV Antibody Levels:
0
0.5
1
1.5
2
2.5
1/
10
0
1/
20
0
1/
40
0
1/
80
0
1/
16
00
1/
32
00
1/
64
00
1/
12
80
0
Dilution
O
D
 a
t 
49
0 
n
m
3/F/C
3/M/C
3/F/I
3/M/I
Legend: 3 – Weeks Old At Infection, F – Female, M – Male, C – Control, I – Infected
Effects of Infection at 3 Weeks of Age on TMEV Antibody Levels:  Infected 
mice had higher levels of virus-specific antibody than controls (ps<0.05).  Males 
infected at three weeks of age were the same as females infected at three weeks of age.
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Figure 15 - Effects of Infection at 4 Weeks of Age on TMEV Antibody Levels:
Legend: 3/4 – Weeks Old At Infection, F – Female, M – Male, C – Control, I – Infected
Effects of Infection at 4 Weeks of Age on TMEV Antibody Levels:  Infected 
mice had higher levels of virus-specific antibody than controls (p<0.05).  
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Figure 16 - Effects of Infection on TMEV Antibody Levels in Females:
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Legend: 2/3 – Weeks Old At Infection, F – Female, M – Male, C – Control, I – Infected
Effects of Infection on TMEV Antibody Levels in Females:  Female mice 
infected at two weeks of age had higher antibody levels than females infected at three 
weeks of age (p=0.003).
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Figure 17 - Effects of Infection on TMEV Antibody Levels in Males:
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Legend: 2/3/4 – Weeks Old At Infection, F – Female, M – Male, C – Control, I – Infected
Effects of Infection on TMEV Antibody Levels in Males:  Males infected at 
two weeks of age had higher antibody levels than males infected at four weeks of age 
(p=0.0343).  
Antibody Assay Summary:  It is interesting to note that the clinical scores 
somewhat reflect a corresponding change in levels of virus-specific antibody.  Firstly, 
infected mice had higher levels of virus-specific antibody than controls (ps<0.05).  
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Males were the same as females at every age infection, meaning that the difference in 
clinical score is not directly substantiated by TMEV levels.  However, differences in 
clinical scores were reflected in the fact that female mice infected at two weeks of age
had higher antibody levels than those infected at three weeks of age (p=0.003). 
Furthermore, the males infected at two weeks of age also had higher antibody levels than 
those infected at four weeks of age (p=0.0343).  This appears to show that a higher 
antibody response is correlating with a lower overall persistence of the virus in each 
mouse and a decrease in behavioral symptoms.  When a correlation was performed, this 
hypothesis was correct (R2=0.918).
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Table 2 - Results of Histological Analysis:
# Showing Lesions (Total) Average Size (%)
Controls 0 (3) 0
2 Weeks of Age 4 (7) 3.06
3 Weeks of Age 5 (7) 2.41
4 Weeks of Age 5 (6) 2.41
Results of Histological Analysis:  Control uninfected mice did not develop 
histological lesions.  Brain lesions were  seen in some of  the infected mice. In order to 
be able to use these results a higher n value will be needed for each group and also spinal 
cord tissue should be examined if the experiment is repeated and more mice should be 
dedicated to histological analysis; 3-4 males and females were used per group, totaling 
to about 7 as shown above.  Due to the small number of mice in each group that actually 
showed lesions in the brain tissue, nothing can be affirmatively said about the 
histological results without more data.
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IV  DISCUSSION
 The results from this study demonstrate that age has a profound effect on the 
pathogenesis of Theiler’s virus infection.  Mice that are infected at one week of age 
develop paralysis and become moribund within 10 days.  The immune system is not 
fully developed at one week which would account for these results.  Interestingly, both 
male and female mice infected at three weeks of age appeared to develop the most 
severe clinical signs of disease.  This finding suggests that other factors contribute to the 
pathogenesis of Theiler’s virus infection.
Overall, since body mass is not affected by infection and rotarod observations are 
not indicative of disease, the prior observation that a younger age at infection correlates 
(R2=0.918) to lower clinical scores and a higher antibody response to TMEV at day 84 
p.i. is extremely important.  Due to the fact that females infected at two weeks of age 
scored higher than males infected at two weeks of age and the severity of disease for 
males infected at three weeks of age is equal to females infected at three weeks of age, 
this difference must be discussed.  A possible cause for the discrepancies between males 
groups compared to the female groups could be (1) estradiol acting as a protective agent 
against the disease for females, supporting previous studies and conclusions or (2) 
testosterone acting as a damaging agent to disease progression in males (Fuller et. al 
2005).  Unfortunately, the after effects of puberty could not be seen in this experiment 
because of the lack of a group of females infected at four weeks of age, but another 
study in C57L/J mice shows a higher severity in males after puberty (Fuller et. al 2005).  
In summary, it appears that clinical scores are lower and antibody response to TMEV is 
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higher in mice infected at two weeks of age.  As time of infection increases, clinical 
scores increase and antibody response drops, likely due to the physiological addition of 
estradiol or testosterone, the former potentially causing a protective effect and the latter 
a negative one.  After puberty has passed, the levels of hormones are still high, but not 
nearly as much as when puberty is taking place, hence the relative drop in clinical 
scores.
These results fit in very well with previous studies that have shown that males 
display worse clinical symptoms compared to females (Alley et. al., 2003; Fuller et. al., 
2005; Fuller et. al., 2007).  This was exactly the case as shown in this study.  In addition, 
two articles discussed puberty in relation to MS – the whole purpose of this research 
model.  One study proposes that multiple sclerosis begins at puberty while the other says 
that “the data suggest that onset… of MS is dependent on passing… through the puberty 
period” (Wainerdi, 1961; Fischman 1981).  The onset of multiple sclerosis and TVID 
both occur prior to puberty, however, data from this experiment supports the latter study 
showing that puberty does have an effect on the pathogenesis, if not the onset of the 
disease.  Also, the data collected shows similarities to the original Theiler studies 
showing that mice infected at very young ages cannot survive infection as well as 
similarities to another study by Steiner, in which data was collected on mice infected at 
one and three weeks of age (Steiner et. al., 1984; Theiler, 1934; Theiler, 1937).  Lastly, 
the overall data in combination with other studies and observations made in the lab point 
to estradiol as being an important agent in the outcome of the disease (Fuller et. al., 
2005).
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On that note, the implication of this study with the support of prior research is 
that further experimentation should take place regarding the effects of puberty.  In order 
to determine what the effects of testosterone or estrogen are on the pathogenesis of 
TVID, a study involving eight groups should be conducted.  First there would be a male 
and a female control group accounting for two of the groups.  Then there would be a 
male and a female group infected at puberty using methods to determine the onset of 
puberty as discussed in another study (Takashima-Sasaki et. al., 2006).  At the same 
time, two other male groups and two other female groups would be infected.  One male 
group would be injected with an estrogen supplement and one female group would be 
injected with a testosterone supplement.  The other male group would be injected with a 
testosterone inhibitor and the last female group would be injected with an estrogen 
inhibitor.  Blood samples should be taken throughout the infection period to determine 
exact estrogen and testosterone levels which can then be compared with clinical scores 
and/or antibody levels.  These groups with varying degrees of estrogen and testosterone 
levels would allow researchers to pinpoint whether either of them has an effect on the 
pathogenesis of TVID, which may have some future value in the treatment of MS 
patients.
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